Skip to main content

Research Repository

Advanced Search

All Outputs (2)

Twice-daily insulin glargine for patients with uncontrolled type 2 diabetes mellitus. (2018)
Journal Article
ELEDRISI, M., SULEIMAN, N.N., SALAMEH, O., HAMAD, M.K., RABADI, O., MOHAMED, A., AL ADAWI, R. and SALAM, A. 2019. Twice-daily insulin glargine for patients with uncontrolled type 2 diabetes mellitus. Journal of clinical and translational endocrinology [online], 15, pages 35-36. Available from: https://doi.org/10.1016/j.jcte.2018.12.002

Insulin glargine is recombinant human insulin analog that is commonly used in patients with type 2 diabetes as well as those with type 1 diabetes. Pharmacokinetic and pharmacodynamics studies of insulin glargine had shown that it has an onset of acti... Read More about Twice-daily insulin glargine for patients with uncontrolled type 2 diabetes mellitus..

Efficacy and safety of once daily liraglutide versus twice daily exenatide in type 2 diabetic patients in Qatar: an observational study. (2018)
Journal Article
JASSIM, Z., ELAJEZ, R., KHUDAIR, I., AL ANANY, R., AL-ADAWI, R.M. 2019. Efficacy and safety of once daily liraglutide versus twice daily exenatide in type 2 diabetic patients in Qatar: an observational study. Journal of pharmaceutical health services research [online], 10(1), pages 73-80. Available from: https://doi.org/10.1111/jphs.12240

Objective: Compare efficacy and safety of liraglutide (1.8 mg subcutaneous once daily) and exenatide (10 mcg subcutaneous twice daily) in uncontrolled type 2 diabetes at 26 and 52 weeks. Method: A retrospective observation study of uncontrolled type... Read More about Efficacy and safety of once daily liraglutide versus twice daily exenatide in type 2 diabetic patients in Qatar: an observational study..